US Federal 2023-2024 Regular Session

US Federal House of Representatives 2023 Bills & Legislation (Page 2)

US

US Federal 2023-2024 Regular Session

US Federal House Bill HB59

Introduced
1/9/23  
Refer
1/9/23  
Save America’s Valuable Energy Act or the SAVE Act This bill directs the Department of Energy (DOE) to prohibit the sale of petroleum products (e.g., crude oil) from the Strategic Petroleum Reserve (SPR) to certain entities. Specifically, DOE must prohibit the sale of petroleum products from the SPR to entities headquartered in Russia. Further, DOE must prohibit the sale of petroleum products from the SPR to entities headquartered in countries (Belarus, Burma, China, Cuba, Iran, North Korea, Syria, and Venezuela) that are subject to certain prohibitions concerning exports of defense articles and services under the Department of State's International Traffic in Arms Regulations.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB28

Introduced
1/9/23  
Illegal Alien NICS Alert Act This bill requires the national instant criminal background check system to notify U.S. Immigration and Customs Enforcement and relevant state and local law enforcement agencies when the system indicates that a prospective firearm transferee is illegally or unlawfully in the United States.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB219

Introduced
1/9/23  
Refer
1/9/23  
No Patient Left Alone Act of 2023 This bill requires hospitals, as a condition of Medicare participation, to have certain written policies and procedures that provide for patient visitation rights and to inform patients of such rights, including any applicable restrictions.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB132

Introduced
1/9/23  
Refer
1/9/23  
Protecting Local Communities from Harmful Algal Blooms Act This bill amends the Robert T. Stafford Disaster Relief and Emergency Assistance Act to include algal blooms in the definition of a major disaster.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB224

Introduced
1/9/23  
Inaction Has Consequences Act This bill withholds the salaries of Members of a chamber of Congress that has not passed each of the annual appropriations bills before the beginning of the fiscal year, beginning with FY2024. Salaries are released on the earlier of (1) the date on which the chamber of Congress passes the bills, or (2) the last day of the Congress.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB167

Introduced
1/9/23  
Refer
1/9/23  
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023 This bill relaxes certain requirements for compounding drugs that are facing shortages. Drug compounding is the process of mixing or otherwise altering drugs to create a medication. Currently, the Food and Drug Administration (FDA) allows for drug compounding subject to certain requirements. Generally, a licensed pharmacist or physician not registered with the FDA may only compound drugs in limited quantities for prescriptions for a specific individual patient. On the other hand, an FDA-registered outsourcing facility may compound drugs in bulk for use in medical facilities but is subject to additional requirements. This bill allows a compounder not registered with the FDA to compound drugs in limited quantities for an urgent medical need not involving a specific patient if, among other requirements (1) the prescriber certifies that the prescriber is unable, despite reasonable attempts, to obtain certain related drugs with the same active ingredient and route of administration; (2) the compounded drug meets certain labeling requirements, including an indication that the compounded drug is provided only for urgent administration to a patient; and (3) the compounder requests and maintains certain records about patients receiving the compounded drug. Furthermore, a restriction against an unregistered compounder regularly compounding (or compounding inordinate amounts of) what is essentially a copy of a commercially available drug shall not apply if the drug is on a shortage list maintained by the FDA or the American Society of Hospital Pharmacists.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB130

Introduced
1/9/23  
Thin Blue Line Act This bill expands the list of statutory aggravating factors in death penalty determinations to also include killing or targeting a law enforcement officer, firefighter, or other first responder.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB552

Introduced
1/26/23  
No Tax Dollars for the United Nation’s Immigration Invasion Act
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB578

Introduced
1/26/23  
PRO Sports Act Properly Reducing Overexemptions for Sports Act
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB572

Introduced
1/26/23  
Ensuring Workers Get PAID Act of 2023
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB573

Introduced
1/26/23  
Refer
1/26/23  
CASE–IT Act Curbing Abuse and Saving Expression In Technology Act
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB546

Introduced
1/26/23  
Refer
1/26/23  
Strengthen the Pediatric Research Initiative Act
US

US Federal 2023-2024 Regular Session

US Federal House Bill HR65

Introduced
1/26/23  
Reaffirming United States-Uzbekistan relations.
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB547

Introduced
1/26/23  
Refer
1/26/23  
Better Care Better Jobs Act
US

US Federal 2023-2024 Regular Session

US Federal House Bill HB557

Introduced
1/26/23  
International Financial Institutions Governance Act of 2023